Chaire de recherche du Canada en génie tissulaire du cartilagegradientChaire Industrielle CRSNG Biosyntech en Biomatériaux Hybrides pour les technologies régénératives innovratrices
 
divider
 
 

Événements récents et à venir

divider
 
 

Félicitations à Myriam Jean!!!

Conférence NanoQuébec 2012
PRIX de RECONNAISSANCE
Meilleure affiche post‐doctorant

10e Congrès Mondial de l'International Cartilage Repair Society

Alternative macrophage activation and neutrophil chemotaxis induced in vivo by chitosan/blood implants correlate with mast cell recruitment
Charles-Hubert Lafantaisie Favreau ….. Caroline D Hoemann

Chitosan modulates the ability of U937 macrophage-like cells to secrete chemokines and attract human bone marrow-derived mesenchymal stem cells
David Fong, Marianne B. Ariganello, Simon Bolduc Beaudoin et Caroline D. Hoemann

- Montréal, Canada - 12-15 mai 2012.

GRSTB Nano-médecine et médecine régénératrice

- Montréal, Canada - 12 avril 2012.

CASEM Sport and Exercise Medicine Conference 2012

- Colombie Britannique, Canada - 20-23 juin 2012.

18th Annual Canadian Connective Tissue Conference

- Toronto, Canada - 8-10 juin.

Canadian Chemistry Conference

- Calgary, Canada - 26-30 mai 2012.

American society of gene and cell therapy

- Philadelphia, USA - 15-19 mai 2012.

International Orthopaedic Sports Medicine & Arthroscopic Surgery

- Shangai, China - 26-28 avril 2012.

NanoQuébec 2012 Conference

System at Low N:P Ratio for Nontoxic Polynucleotide Delivery
M. Alameh, D. De Jesus, M. Jean, R.M Derbali, M. Benhammadi, C.Y. Chang, V. Darras, M. Thibault, M. Lavertu, M.D Buschmann, A. Merzouki

In vitro evaluation and physico-chemical characterization of low molecular weight chitosan-siRNA nanoparticles targeting the ApolipoproteinB: a feasibility study.
R.M Derbali, M. Alameh, M. Jean, C.Y Chang, M. Thibault, M. Lavertu, V. Lascau, M. Nelea, M.D. Buschmann, A. Merzouki.

Chitosan-based nanoparticles for GLP-1 gene delivery and DPP-IV gene silencing of in vitro cell lines relevant to type 2 diabetes.
Jean M. , Alameh M., Chang C.Y., Thibault M., Lavertu M., Darras V., Nelea M., Lascau V., Buschmann M.D., Merzouki A.

- Montréal, Canada - 20-21 mars 2012.

American Chemical Society National Meeting

- San Diego, USA - 25-29 mars 2012.

Orthopaedic Research Society Annual Meeting

Subchondral Pre-solidified Chitosan-Blood Implants Degrade In Situ and Elicit PMNs, Osteoclasts, Subchondral Plate Remodeling, and Delayed Chondroinduction at 3 weeks in a Rabbit Model of Marrow Stimulation
Charles-Hubert Lafantaisie Favreau, Jessica Guzmàn-Morales, Jun Sun, Gaoping Chen, Adam Harris, Duncan Smith, Alberto Carli, Janet E Henderson, William D Stanish, Caroline D Hoemann

- San Francisco, USA - 4-7 février 2012.

10th IEEE International Conference on Solid Dielectrics, July 2010, Potsdam, Germany

Electro-deformation of individual mammalian cells in suspension. MacQueen LA, Buschmann MD, Wertheimer MR.

American society of gene and cell therapy

Effective and safe gene-based delivery of GLP-1 using chitosan/plasmid-DNA therapeutic nanocomplexes in an animal model of Type 2 Diabetes.
M. Jean, M. Alameh, V. Daras, M. Lavertu, M. Thibault, M.D. Buschmann, A. Merzouki.

- Seattle, USA - 18-21 mai 2011.

Controlled Release Society

Chitosan nanoparticulate system for the delivery of siRNA targeting genome caretakers for the development of potential cancer therapies.
M. Alameh, D. De Jesus, M. Jean, M. Benhamadi, M.D. Buschmann, A. Merzouki.

Therapeutic lowering of circulating ApoB in atherosclerotic mice by intravenous administration of chitosan-siRNA nanoparticles.
D. DeJesus, M. Alameh, M. Jean, V. Lascau, M.D. Buschmann, A. Merzouki.

Effective and safe gene-based delivery of GLP-1 using chitosan/plasmid-DNA therapeutic nanocomplexes in an animal model of Type 2 Diabetes.
M. Jean, M. Alameh, V. Darras, M. Lavertu, M. Thibault, M.D. Buschmann, A. Merzouki.

- Montréal - Mai 2011.

OARSI World Congress on Osteoarthritis, Montreal September 2009

Bone Marrow Stimulation by Drilling Versus Microfracture Leads to Better Articular Cartilage Repair in Rabbits. Chen H, Hoemann CD, Sun J, Ouyang W, Dragomir L, Chevrier A, Lascau-Coman V, Tran-Khanh N, McKee MD, Shive MS, Buschmann MD

Streaming Potential-Based Arthroscopic Device Can Detect Changes Immediately Following Localized Impact in an Equine Impact Model of Osteoarthritis. Changoor A, Quenneville E, Garon M, Hurtig MB, Buschmann MD

Dexamethasone Inhibits Gelatinase Activity During in vitro Osteogenesis of Human Bone Marrow Stromal Cells. Guzman-Morales J, Chevrier A, Wu W and Hoemann CD.

Challenges in Designing Randomized Clinical Trials for Cartilage Repair: The BST-CarGel ® Experience. Restrepo A, WD Stanish, CD Hoemann, MD Buschmann, MS Shive



Association Francophone pour le Savoir

Caractérisation des nanocomplexes chitosane/ODNs apoB par les techniques d’électrophorèse sur gel de polyacrylamide, DLS et ESEM.
De Jesus D. L., Alameh M.-G., Jean M., Buschmann M., Merzouki A.

- Montréal - 2010.

CANADIAN CONNECTIVE TISSUE CONFERENCE, July 17-18 2009

Dr. Michael Buschmann, Keynote – DNA and RNA delivery using polymeric nanoparticles

Assessment of Collagen Orientation in Repair Cartilage by Polarized Light and Scanning Electron Microscopies Adele Changoor, Monica Nelea, Nicolas Tran-Khanh, Stephane Methot, Liah Fereydoozad, Evgheny Rossomacha, Julie Tremblay, Matthew S. Shive, Michael B. Buschmann

Bone-marrow stimulation by Drilling Versus Microfracture Improves Cartilage Repair in a Mature Rabbit Model Hongmei Chen, Caroline D. Hoemann, Jun Sun, Wei Ouyang, Liviu Dragomir, Anik Chevrier, Viorica Lascau-Coman, Nicolas Tran-Khanh, Marc D. McKee, Matthew S. Shive, Michael D. Buschmann

Streaming Potential-Based Arthroscopic Device Can Detect Changes Immediately FollowingLocalized Impact in an Equine Impact Model of Osteoarthritisherapeutic and Diagnostic Technologies for Articular Cartilage Adele Changoor, Eric Quenneville, Martin Garon, Mark B. Hurtig, Michael D. Buschmann

GRSTB Journée de la Recherche

Chitosan-plasmid nanoparticle formulations for IM and SC delivery of recombinant FGF-2 and PDGF-BB or generation of antibodies.
Jean M., Smaoui F, Lavertu M, Buschmann MD, Merzouki A .

- Montréal - 2009.